Drug Profile
Research programme: cyclo-oxygenase-2 inhibitors - Esteve
Alternative Names: COX-2 inhibitors research programme - Esteve; Cyclo-oxygenase-2 inhibitors research programme - Esteve; Research programme: COX-2 inhibitors - EsteveLatest Information Update: 18 Jul 2006
Price :
$50
*
At a glance
- Originator Esteve
- Class
- Mechanism of Action Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Osteoarthritis; Pain
Most Recent Events
- 18 Jul 2006 No development reported - Preclinical for Cancer in Spain (unspecified route)
- 18 Jul 2006 No development reported - Preclinical for Osteoarthritis in Spain (unspecified route)
- 18 Jul 2006 No development reported - Preclinical for Pain in Spain (unspecified route)